Michael A. Ross's most recent trade in 20/20 Biolabs Inc was a trade of 31 Series A-2 Preferred Stock done . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020 Biolabs Inc | Michael A. Ross | Director | 19 Feb 2026 | 31 | 0 | - | - | Series A-2 Preferred Stock | ||
| 2020 Biolabs Inc | Michael A. Ross | Director | 19 Feb 2026 | 31 | 31 | - | 0 | Common Stock |